𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Calcium/Calmodulin-dependent protein kinase activity in primary astrocyte cultures

✍ Scribed by E. Babcock-Atkinson; Dr. M.D. Norenberg; L.O.B. Norenberg; J.T. Neary


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
725 KB
Volume
2
Category
Article
ISSN
0894-1491

No coin nor oath required. For personal study only.

✦ Synopsis


Calcium, calmodulin-dependent protein kinase (Ca/CaM kinase) is a n important component of calcium signalling mechanisms in the brain, but little is known about the properties of this protein phosphorylation system in astrocytes. Addition of calcium and calmodulin to supernatant or membrane fractions obtained from rat astrocytes in primary culture increased phosphate incorporation into a n exogenously added substrate, casein, and into endogenous protein substrates; this increase was greater than that observed with either calcium alone or calmodulin alone. The calcium. calmodulinstimulated increase was inhibited by trifluoperazine, and this inhibition could be overcome by the addition of excess calmodulin. The major substrates for Ca,'CaM kinase activity were proteins with molecular weights of 59 and 53 kDa, which were similar, but not identical, to the subunits of Ca/CaM kinase type II from brain. The specific activity of Ca/CaM kinase and the phosphorylation of 59 kDa were increased in astrocyte cultures treated and maintained in dibutyryl cyclic adenosine monophosphate (dBcAMP). These results indicate that astrocytes contain Ca/CaM kinase activity and suggest a n interaction between the CAMP and calcium/calmodulin messenger systems in these cells.


πŸ“œ SIMILAR VOLUMES


Separation of calmodulin from calcium-ac
✍ N.H. Battey; M.A. Venis πŸ“‚ Article πŸ“… 1988 πŸ› Elsevier Science 🌐 English βš– 1020 KB

To determine whether a Ca2+-activated protein kinase is regulated by calmodulin, it is necessary to separate it from endogenous calmodulin and from protein kinase activity that is not calcium dependent. We describe here a procedure for achieving these goals using Ca2+-dependent hydrophobic interacti

Methamphetamine decreases calcium-calmod
✍ Junko Suemaru; Kazufumi Akiyama; Yasuyuki Tanabe; Shigetoshi Kuroda πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 271 KB πŸ‘ 2 views

A Ca(2+)/calmodulin-dependent signaling cascade has been implicated in the regulation of dopaminergic neurotransmission after chronic administration of amphetamine and methamphetamine (METH). We found a decrease in Ca(2+)/calmodulin-dependent protein kinase II (CaM-kinase II) activity in five region

Activation of CA2+/calmodulin-dependent
✍ Jiro Kasahara; Kohji Fukunaga; Eishichi Miyamoto πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 2 views

Ca 2Ο© /calmodulin-dependent protein kinase IV (CaM kinase IV) is a multifunctional enzyme that is abundantly present in the nuclei of neurons. We report the properties of phosphorylation and activation of CaM kinase IV in comparison to CaM kinase II in cultured rat hippocampal neurons. Phosphorylati

Calcium/calmodulin-dependent protein kin
✍ Lund, Linda M. ;McQuarrie, Irvine G. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 391 KB πŸ‘ 2 views

Although Ca 2/ /calmodulin-depen-mRNA increase. We were unable to find CaM kinase dent (CaM) protein kinase II isoforms are present in IIa immunoreactivity before or after axotomy in scithe nervous system in high amounts, many aspects of atic motor neuron cell bodies, suggesting that CaM in vivo exp

Involvement of calcium/calmodulin-depend
✍ Kazumi Nomura; Yusuke Takeuchi; Shun Yamaguchi; Hitoshi Okamura; Kohji Fukunaga πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 384 KB

Recent studies suggest that CaM kinase II is involved in light-induced phase delays and induction of Per1 and Per2 genes in the hamster suprachiasmatic nucleus (SCN) (Yokota et al.,2001). We focused on intracellular mechanisms of the CaM kinase II-induced mPer1 gene expression. Immunoblotting and im

Galantamine enhancement of long-term pot
✍ Shigeki Moriguchi; Norifumi Shioda; Feng Han; Jay Z. Yeh; Toshio Narahashi; Kohj πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 652 KB

## Abstract Galantamine, a novel Alzheimer's drug, is known to inhibit acetylcholinesterase activity and potentiate nicotinic acetylcholine receptor (nAChR) in the brain. We previously reported that galantamine potentiates the NMDA‐induced currents in primary cultured rat cortical neurons. We now s